Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Cortisol cut-points for the glucagon stimulation test in the evaluation of hypothalamic pituitary adrenal axis.

Ach T, Yosra H, Jihen M, Abdelkarim Asma B, Maha K, Molka C, Rouatbi S, Monia Z, Ach K.

Endocr J. 2018 Sep 27;65(9):935-942. doi: 10.1507/endocrj.EJ18-0147. Epub 2018 Jun 27.

2.

Macroprolactinemia and Empty Sella Syndrome.

Taieb A, Maha KN, El Abed YH, Beizig AM, Chadli MC, Ach K.

Pan Afr Med J. 2017 Aug 14;27:278. doi: 10.11604/pamj.2017.27.278.11361. eCollection 2017.

3.

[Prolactin-secreting microadenoma in menopausal women].

Barka I, Dendana E, Chikhrouhou N, Maroufi A, Kacem M, Chadli M, Ach K.

Pan Afr Med J. 2017 Jul 5;27:177. doi: 10.11604/pamj.2017.27.177.11677. eCollection 2017. French.

4.

High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome.

Bubien V, Bonnet F, Brouste V, Hoppe S, Barouk-Simonet E, David A, Edery P, Bottani A, Layet V, Caron O, Gilbert-Dussardier B, Delnatte C, Dugast C, Fricker JP, Bonneau D, Sevenet N, Longy M, Caux F; French Cowden Disease Network.

J Med Genet. 2013 Apr;50(4):255-63. doi: 10.1136/jmedgenet-2012-101339. Epub 2013 Jan 18.

PMID:
23335809
5.

Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients.

Slimani A, Jelassi A, Jguirim I, Najah M, Rebhi L, Omezzine A, Maatouk F, Hamda KB, Kacem M, Rab├Ęs JP, Abifadel M, Boileau C, Rouis M, Slimane MN, Varret M.

Atherosclerosis. 2012 May;222(1):158-66. doi: 10.1016/j.atherosclerosis.2012.02.018. Epub 2012 Feb 19.

PMID:
22417841
6.

A whole mitochondrial genome screening in a MELAS patient: a novel mitochondrial tRNA(Val) mutation.

Mezghani N, Mnif M, Kacem M, Mkaouar-Rebai E, Hadj Salem I, Kallel N, Charfi N, Abid M, Fakhfakh F.

Biochem Biophys Res Commun. 2011 Apr 22;407(4):747-52. doi: 10.1016/j.bbrc.2011.03.094. Epub 2011 Apr 3.

PMID:
21447323
7.

Graves' disease associated with cerebrovascular disease and antiphospholipid antibody syndrome.

Khochtali I, Hamza N, Gassab E, Baba A, Kacem M, Frih M, Mahjoub S.

Int J Endocrinol. 2010;2010. pii: 624152. doi: 10.1155/2010/624152. Epub 2010 Sep 2.

8.

Common polymorphisms of calpain-10 and the risk of Type 2 Diabetes in a Tunisian Arab population: a case-control study.

Ezzidi I, Turki A, Messaoudi S, Chaieb M, Kacem M, Al-Khateeb GM, Mahjoub T, Almawi WY, Mtiraoui N.

BMC Med Genet. 2010 May 15;11:75. doi: 10.1186/1471-2350-11-75.

9.

A novel nonsense mutation in the albumin gene (c.1275 C>A) causing analbuminemia in a Tunisian boy.

Caridi G, Kacem M, Campagnoli M, Dagnino M, Debbabi W, Kochtali I, Neffati F, Galliano M, Minchiotti L.

Clin Chem Lab Med. 2009;47(10):1311-3. doi: 10.1515/CCLM.2009.289. No abstract available.

PMID:
19803814
10.

Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy.

Ezzidi I, Mtiraoui N, Kacem M, Chaieb M, Mahjoub T, Almawi WY.

Diabetes Metab Res Rev. 2009 Nov;25(8):717-24. doi: 10.1002/dmrr.1006.

PMID:
19787680
11.

Contribution of type 2 diabetes associated loci in the Arabic population from Tunisia: a case-control study.

Ezzidi I, Mtiraoui N, Cauchi S, Vaillant E, Dechaume A, Chaieb M, Kacem M, Almawi WY, Froguel P, Mahjoub T, Vaxillaire M.

BMC Med Genet. 2009 Apr 15;10:33. doi: 10.1186/1471-2350-10-33.

12.

Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients.

Mtiraoui N, Ezzidi I, Kacem M, Ben Hadj Mohamed M, Chaieb M, Haj Jilani AB, Mahjoub T, Almawi WY.

Diabetes Metab Res Rev. 2009 Jan;25(1):57-63. doi: 10.1002/dmrr.892.

PMID:
19031431
13.

Interleukin-10-592C/A, -819C/T and -1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients.

Ezzidi I, Mtiraoui N, Kacem M, Mallat SG, Mohamed MB, Chaieb M, Mahjoub T, Almawi WY.

Clin Endocrinol (Oxf). 2009 Mar;70(3):401-7. doi: 10.1111/j.1365-2265.2008.03337.x. Epub 2008 Jun 27.

PMID:
18616700
14.

Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene variants with diabetic nephropathy.

Ezzidi I, Mtiraoui N, Mohamed MB, Mahjoub T, Kacem M, Almawi WY.

J Diabetes Complications. 2008 Sep-Oct;22(5):331-8. doi: 10.1016/j.jdiacomp.2007.11.011. Epub 2008 Apr 16.

PMID:
18413207
15.

Endothelial nitric oxide synthase Glu298Asp, 4b/a, and T-786C polymorphisms in type 2 diabetic retinopathy.

Ezzidi I, Mtiraoui N, Mohamed MB, Mahjoub T, Kacem M, Almawi WY.

Clin Endocrinol (Oxf). 2008 Apr;68(4):542-6. Epub 2007 Oct 31.

PMID:
17973941
16.

One year course of oral sulodexide in the management of diabetic nephropathy.

Achour A, Kacem M, Dibej K, Skhiri H, Bouraoui S, El May M.

J Nephrol. 2005 Sep-Oct;18(5):568-74.

PMID:
16299683
17.

[Disposal of insulin syringes by diabetic patients. Report of 100 patients].

Dallel N, Kacem M, Nabouli RM, El May M.

Tunis Med. 2005 Jul;83(7):390-2. French.

PMID:
16220694
18.

Hypothyroidism presenting as a hot pertechnetate nodule.

Boughattas S, Arifa N, Kacem M, Chatti K, Riahi N, Hassine H, Essabbah H.

Ann Nucl Med. 2003 Sep;17(6):495-8.

PMID:
14575386

Supplemental Content

Loading ...
Support Center